Nurse Practitioner, Family · Louisville, KY
NPI
1962871327
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
140 Whittington Pkwy 100
Louisville, KY, 40222
Phone (502) 327-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,600
87 services
Medicare patients, 2024
58
Average age 66
Drug cost, 2024
$2.6M
755 prescriptions
Company payments, 2025
$97.13
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danielle Revert was code 99214 (office e&m - established), 56 times for 42 patients. In total Danielle Revert billed 87 services in 3 codes, and Medicare paid $5,600.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 56 | 42 | $64.85 | $3,631 |
| 99204 Office E&M - New | Office | 11 | 11 | $99.56 | $1,095 |
By year: 2022 $3,433 for 60 services; 2023 $4,878 for 79 services; 2024 $5,600 for 87 services.
Medicare prescription drug claims, 2024
In 2024, the drug Danielle Revert prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 309 prescriptions and refills. In total Danielle Revert wrote 755 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xifaxan Rifaximin | 309 | 309 | 40 | $977K |
| Constulose Lactulose | 71 | 76 | 21 | $926 |
| Entecavir Generic | 68 | 90 | 16 | $15K |
| Lactulose Generic | 66 | 92 | 20 | $2,030 |
| Epclusa Sofosbuvir/Velpatasvir | 57 | 57 | 19 | $1.3M |
| Vemlidy Tenofovir Alafenamide | 42 | 42 | Under 11 | $56K |
| Spironolactone Generic | 38 | 59 | Under 11 | $284 |
| Furosemide Generic | 23 | 36 | Under 11 | $36.99 |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 11 | 11 | Under 11 | $88K |
Brand drugs: 447 claims; generic drugs: 308 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danielle Revert $97.13 ($97.13 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $97.13.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $97.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.